Invex Therapeutics Ltd. (AU:IXC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Invex Therapeutics Ltd has issued a final notice regarding the interests of departing director Dr. Megan Baldwin, who served until June 30, 2024. The notice includes Baldwin’s direct and indirect holdings, notably 50,000 unlisted options exercisable at $0.68 until December 1, 2026, through GAJA Holdings Pty Ltd, where she is a director and beneficial holder.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.